In recent years, target-based drug discovery has undergone a renaissance thanks to polypharmacology. In contrast to the conventional lock-and-key or one target-one drug model of drug design, polypharmacology is a multitargeted approach for improving the efficacy and safety of new and existing pharmaceuticals.
Download this infographic from The Scientist to learn about polypharmacology’s historical challenges, potential benefits, and the latest advances that help make this approach to target-based drug discovery more feasible.
